FDA label
What is dalfampridine used for?
The FDA-approved uses of dalfampridine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Dalfampridine Extended-Release Tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies].”
Run it in Rivvi
Which 2027 plans near you dropped or restricted dalfampridine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Dalfampridine, tablet, film coated, extended release
Indications and Usage, quoted from the label by Accord Healthcare Inc. (ANDA206863). Cross-references to other label sections are left out.
Dalfampridine Extended-Release Tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies].
Source: DailyMed label, set id 354a97e8-35c8-418b-91b2-9e8e066cec65, version 8, effective October 9, 2025. NDC 16729-292, one of 6 listings for this product.
Dalfampridine, tablet, extended release
Indications and Usage, quoted from the label by Micro Labs Limited (ANDA210158). Cross-references to other label sections are left out.
Dalfampridine extended-release tablet is indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed.
Source: DailyMed label, set id 302c8270-4711-4ca4-bee8-be0738fbe094, version 9, effective July 28, 2025. NDC 42571-275, one of 3 listings for this product.
Questions
What is dalfampridine used for?
The FDA label says: “Dalfampridine Extended-Release Tablets are indicated as a treatment to improve walking in adult patients with multiple sclerosis (MS). This was demonstrated by an increase in walking speed [see Clinical Studies].”
What drug class is dalfampridine?
FDA lists dalfampridine in the Potassium Channel Blocker established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.